HIGHLIGHTS
- who: Jelena Vekic et al. from the Department of Medical Biochemistry, University of Belgrade-Faculty of Pharmacy, Belgrade, SerbiaUniversity of Palermo, Palermo, Italy have published the Article: Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL, in the Journal: Pharmaceutics 2022, 14, 825. of /2022/
- what: Even though sdLDL has been long recognized as an essential feature of atherosclerosis development, it is still neither a part of the routine assessment of CVD risk, nor a specific therapeutic target.
- how: This paper discusses the potential of traditional and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.